MedPath

Evaluating the Efficacy of the Parent Support Program

Not Applicable
Completed
Conditions
Prejudice
Knowledge, Attitudes, Practice
Gender Identity
Registration Number
NCT04531761
Lead Sponsor
Palo Alto University
Brief Summary

The objective of the study is to evaluate the efficacy of an online intervention (the Parents Support Program) aimed at increasing supportive behaviors among parents of transgender youth. The intervention consists of three modules that include a variety engaging activities such as social perspective taking exercises, writing prompts, videos of parents, youth, and experts, and psycho-educational materials. The study uses an experimental design with a waitlist control. Both the experimental and control groups will complete a pre-test, one month follow up, and two month follow up survey. Targeted outcomes include knowledge about gender diversity, attitudes about trans youth, and supportive parenting behaviors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
570
Inclusion Criteria
  • Must be 18 years of age or older.
  • Must live in the United States.
  • Must be comfortable communicating in English.
  • Must be a parent of a trans child between the ages of 10 - 24.
Exclusion Criteria
  • Participants who participated in pilot study or focus groups related to this project.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Trans-supportive behaviors scaleOne month

This 20 item questionnaire measures the frequency of supportive behaviors enacted in the past month. Response options ranged from 1 (never) to 5 (frequently) based on item anchors from the Ryan et al. (2010) measure on family acceptance. The original 25-item scale was reduced to 20 items based on achieving adequate internal consistency reliability in a previous study with parents of trans youth (Matsuno \& Israel, in preparation). An example item is: "I told my child I respect and support them." The measure showed adequate internal consistency reliability in the pilot study of the Parent Support Program (α = .8).

Secondary Outcome Measures
NameTimeMethod
Attitudes Toward Trans Youth Scale (ATTYS - Birnkrant, 2018)One month

Two subscales of the original scale were used consisting of 27 items- Genderism, and Fabricated Identity. The scale had strong reliablity α = .98 and demonstrated convergent and discriminant validity.

Objective knowledge about gender diversityOne month

The author created a 18-item measure designed to test knowledge about constructs of gender and experiences of transgender people. The items are based on the program content and through best practices for creating multiple choice questions.

Subjective knowledge about gender diversityOne month

Participants perceptions of their own level knowledge regarding gender diversity will be measured using a 100-point Likert scale from 1 - not at all knowledgeable to 100- extremely knowledgeable. Participants will be asked to rate their perceived knowledge in the following areas: gender terminology, etiology, medical intervention, and impact of parental acceptance.

Self-compassionOne month

Self-compassion was measured by adapting the self-kindness subscale of the Self-Compassion Scale - Short Form (SCS-SF) (Raes, Pommier, Neff, \& Van Gucht, 2011). The subscale demonstrated adequate reliability in a previous sample (α = .78) (Raes et al., 2011). The five items were adapted by adding "as a parent of a trans/non-binary child" at the end of each item to measure self-compassion related to parenting a trans child. Items were rated on a 5-point Likert scale ranging from 1 (almost never) to 5 (almost always). The measure showed strong internal consistency reliability in the pilot study of the Parent Support Program (α = .94).

Trial Locations

Locations (1)

Palo Alto University

🇺🇸

Palo Alto, California, United States

Palo Alto University
🇺🇸Palo Alto, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.